References
- Steffen B, Muller-Tidow C, Schwable J, et al. The molecular pathogenesis of acute myeloid leukemia. Crit Rev Oncol Hematol. 2005;56(2):195–221.
- Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
- Miranda-Filho A, Pineros M, Ferlay J, et al. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol. 2018;5(1):e14–e24.
- Roman E, Smith A, Appleton S, et al. Myeloid malignancies in the real-world: occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004–15. Cancer Epidemiol. 2016;42:186–198.
- Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724–3734.
- Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 2012;119(1):34–43.
- Srour SA, Devesa SS, Morton LM, et al. Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001–12. Br J Haematol. 2016;174(3):382–396.
- So CC, Wan TS, Chow JL, et al. A single-center cytogenetic study of 629 Chinese patients with de novo acute myeloid leukemia—evidence of major ethnic differences and a high prevalence of acute promyelocytic leukemia in Chinese patients. Cancer Genet. 2011;204(8):430–438.
- Li X, Li X, Xie W, et al. Comprehensive profile of cytogenetics in 2308 Chinese children and adults with de novo acute myeloid leukemia. Blood Cells Mol Dis. 2012;49(2):107–113.
- Bassig BA, Au WY, Mang O, et al. Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001–2010. Cancer Epidemiol. 2016;42:15–23.
- Chihara D, Ito H, Matsuda T, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164(4):536–545.
- Thun MJ, Linet MS, Cerhan JR, et al. Schottenfeld and Fraumeni cancer epidemiology and prevention. 4th ed. New York, NY: Oxford University Press; 2017.
- Jackson N, Menon BS, Zarina W, et al. Why is acute leukemia more common in males? A possible sex-determined risk linked to the ABO blood group genes. Ann Hematol. 1999;78(5):233–236.
- Fircanis S, Merriam P, Khan N, et al. The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies. Am J Hematol. 2014;89(8):E125–E132.
- Li S, Chen L, Jin W, et al. Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: a meta-analysis. Sci Rep. 2017;7(1):17998.
- Smith MT, Zhang L, McHale CM, et al. Benzene, the exposome and future investigations of leukemia etiology. Chem Biol Interact. 2011;192(1–2):155–159.
- Leal AD, Thompson CA, Wang AH, et al. Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in the Iowa Women's Health Study Cohort. Int J Cancer. 2014;134(7):1741–1750.
- Leal AD, Thompson CA, Wang AH, et al. Hormonal and reproductive factors and risk of myeloproliferative neoplasms in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2016;25(1):151–157.
- Ugai T, Matsuo K, Oze I, et al. Smoking and subsequent risk of acute myeloid leukaemia: a pooled analysis of 9 cohort studies in Japan. Hematol Oncol. 2018;36(1):262–268.
- Linet MS, Gilbert ES, Vermeulen R, et al. Benzene exposure response and risk of myeloid neoplasms in Chinese workers: a multicenter case-cohort study. J Natl Cancer Inst. 2019;111(5):465–474.
- Cogle CR. Incidence and burden of the myelodysplastic syndromes. Curr Hematol Malig Rep. 2015;10(3):272–281.
- Bray F, Colombet M, Mery L, et al., editors. Cancer incidence in five continents. Vol. XI. IARC scientific publication no. 166. Lyon: International Agency for Research on Cancer; 2021.